Pretreatment but not treatment with probiotics abolishes mouse intestinal barrier dysfunction in acute pancreatitis

Surgery

Volumn 145, Issue 2, 2009, Pages 157-167

  Rychter, Jakub W ^a,b   van Minnen, L Paul ^a   Verheem, André ^a   Timmerman, Harro M ^a   Rijkers, Ger T ^a,c,d   Schipper, Marguerite E I ^a   Gooszen, Hein G ^a   Akkermans, Louis M A ^a   Kroese, Alfons B A ^a,b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d ST ANTONIUS HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CERULETIDE; ECOLOGIC; PLACEBO; PROBIOTIC AGENT; UNCLASSIFIED DRUG;

ACUTE PANCREATITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; HISTOPATHOLOGY; INTESTINAL BARRIER DYSFUNCTION; INTESTINE FUNCTION DISORDER; LUNG PARENCHYMA; MALE; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; STEADY STATE;

ANIMALS; BACTERIAL TRANSLOCATION; BIFIDOBACTERIUM; CAERULEIN; ILEAL DISEASES; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS CASEI; LACTOCOCCUS LACTIS; LUNG; MALE; MICE; PANCREAS; PANCREATITIS; PROBIOTICS;

EID: 58349099422     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surg.2008.09.011     Document Type: Article

References (39)

1. Rahman S.H., Ammori B.J., Holmfield J., Larvin M., and McMahon M.J. Intestinal hypoperfusion contributes to gut barrier failure in severe acute pancreatitis. J Gastrointest Surg 7 (2003) 26-35
2. Van Felius I.D., Akkermans L.M., Bosscha K., Verheem A., Harmsen W., Visser M.R., et al. Interdigestive small bowel motility and duodenal bacterial overgrowth in experimental acute pancreatitis. Neurogastroenterol Motil 15 (2003) 267-276
3. Flint R.S., and Windsor J.A. The role of the intestine in the pathophysiology and management of severe acute pancreatitis. HPB 5 (2003) 69-85
4. Hotz H.G., Foitzik T., Rohweder J., Schulzke J.D., Fromm M., Runkel N.S., et al. Intestinal microcirculation and gut permeability in acute pancreatitis: early changes and therapeutic implications. J Gastrointest Surg 2 (1998) 518-525
5. Ammori B.J., Leeder P.C., King R.F., Barclay G.R., Martin I.G., Larvin M., et al. Early increase in intestinal permeability in patients with severe acute pancreatitis: correlation with endotoxemia, organ failure, and mortality. J Gastrointest Surg 3 (1999) 252-262
6. Beger H.G., Rau B., Mayer J., and Pralle U. Natural course of acute pancreatitis. World J Surg 21 (1997) 130-135
7. Dugernier T.L., Laterre P.F., Wittebole X., Roeseler J., Latinne D., Reynaert M.S., et al. Compartmentalization of the inflammatory response during acute pancreatitis: correlation with local and systemic complications. Am J Respir Crit Care Med 168 (2003) 148-157
8. Swank G.M., and Deitch E.A. Role of the gut in multiple organ failure: Bacterial translocation and permeability changes. World J Surg 20 (1996) 411-417
9. van der Poll T. Immunotherapy of sepsis. Lancet Infect Dis 1 (2001) 165-174
10. Isenmann R., and Beger H.G. Natural history of acute pancreatitis and the role of infection. Baillieres Best Pract Res Clin Gastroenterol 13 (1999) 291-301
11. Widdison A.L., and Karanjia N.D. Pancreatic infection complicating acute pancreatitis. Br J Surg 80 (1993) 148-154
12. Buchler M.W., Gloor B., Muller C.A., Friess H., Seiler C.A., and Uhl W. Acute necrotizing pancreatitis: treatment strategy according to the status of infection. Ann Surg 232 (2000) 619-626
13. Schrezenmeir J., and De Vrese M. Probiotics, prebiotics, and synbiotics-approaching a definition. Am J Clin Nutr 73 (2001) 361-364
14. Bergonzelli G.E., Blum S., Brussow H., and Corthesy-Theulaz I. Probiotics as a treatment strategy for gastrointestinal diseases?. Digestion 72 (2005) 57-68
15. Quigley E.M., and Flourie B. Probiotics and irritable bowel syndrome: a rationale for their use and an assessment of the evidence to date. Neurogastroenterol Motil 19 (2007) 166-172
16. Petrof E.O., Kojima K., Ropeleski M.J., Musch M.W., Tao Y., De Simone C., et al. Probiotics inhibit nuclear factor-kappaB and induce heat shock proteins in colonic epithelial cells through proteasome inhibition. Gastroenterology 127 (2004) 1474-1487
17. Timmerman H.M., Koning C.J.M., Mulder L., Rombouts F.M., and Beynen A.C. Monostrain, multistrain and multispecies problotics-a comparison of functionality and efficacy. Int J Food Microbiol 96 (2004) 219-233
18. Mangiante G., Colucci G., Canepari P., Bassi C., Nicoli N., Casaril A., et al. Lactobacillus plantarum reduces infection of pancreatic necrosis in experimental acute pancreatitis. Dig Surg 18 (2001) 47-50
19. van Minnen L.P., Timmerman H.M., Lutgendorff F., Verheem A., Harmsen W., Konstantinov S.R., et al. Modification of intestinal flora with multispecies probiotics reduces bacterial translocation and improves clinical course in a rat model of acute pancreatitis. Surgery 141 (2007) 470-480
20. Olah A., Belagyi T., Issekutz A., Gamal M.E., and Bengmark S. Randomized clinical trial of specific lactobacillus and fibre supplement to early enteral nutrition in patients with acute pancreatitis. Br J Surg 89 (2002) 1103-1107
21. Besselink M.G., van Santvoort H.C., Buskens E., Boermeester M.A., van Goor H., Timmerman H.M., et al. Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. The Lancet 371 (2008) 651-659
22. Foitzik T., Hotz H.G., Eibl G., and Buhr H.J. Experimental models of acute pancreatitis: are they suitable for evaluating therapy?. Int J Colorectal Dis 15 (2000) 127-135
23. Timmerman H.M., Niers L.E.M., Ridwan B.U., Koning C.J.M., Mulder L., Akkermans L.M.A., et al. Design of a multispecies probiotic mixture to prevent infectious complications in critically ill patients. Clinical Nutr 26 (2007) 450-459
24. Demols A., Le Moine O., Desalle F., Quertinmont E., Van Laethem J.L., and Deviere J. CD4(+)T cells play an important role in acute experimental pancreatitis in mice. Gastroenterology 118 (2000) 582-590
25. Lightner A.M., Jordan T.H., Bunnett N.W., Grady E.F., and Kirkwood K.S. Recombinant human neutral endopeptidase ameliorates pancreatic elastase-induced lung injury. Surgery 132 (2002) 193-199
26. Bradley P.P., Priebat D.A., Christensen R.D., and Rothstein G. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol 78 (1982) 206-209
27. Clausen A.E., and Bernkop-Schnurch A. Thiolated carboxymethylcellulose: in vitro evaluation of its permeation enhancing effect on peptide drugs. Eur J Pharm Biopharm 51 (2001) 25-32
28. Frossard J.L., Hadengue A., Spahr L., Morel P., and Pastor C.M. Natural history of long-term lung injury in mouse experimental pancreatitis. Crit Care Med 30 (2002) 1541-1546
29. Chan Y.C., and Leung P.S. Acute pancreatitis: animal models and recent advances in basic research. Pancreas 34 (2007) 1-14
30. Schulzke J.D., Gitter A.H., Mankertz J., Spiegel S., Seidler U., Amasheh S., et al. Epithelial transport and barrier function in occludin-deficient mice. Biochimica et Biophysica Acta-Biomembranes 1669 (2005) 34-42
31. Schulzke J.D., Fromm M., and Hegel U. Epithelial and subepithelial resistance of rat large intestine: segmental differences, effect of stripping, time course, and action of aldosterone. Pflugers Arch 407 (1986) 632-637
32. Zareie M., Johnson-Henry K., Jury J., Yang P.C., Ngan B.Y., Mckay D.M., et al. Probiotics prevent bacterial translocation and improve intestinal barrier function in rats following chronic psychological stress. Gut 55 (2006) 1553-1560
33. Karczewski J., and Groot J. Molecular physiology and pathophysiology of tight junctions III. Tight junction regulation by intracellular messengers: differences in response within and between epithelia. Am J Physiol Gastrointest Liver Physiol 279 (2000) G660-G665
34. Mosenthal A.C., Xu D., and Deitch E.A. Elemental and intravenous total parenteral nutrition diet-induced gut barrier failure is intestinal site specific and can be prevented by feeding nonfermentable fiber. Crit Care Med 30 (2002) 396-402
35. Berg R.D. Bacterial translocation from the gastrointestinal tract. Adv Exp Med Biol 473 (1999) 11-30
36. Deitch E.A., Lu Q., Feketeova E., Hauser C.J., and Xu D.Z. Intestinal bacterial overgrowth induces the production of biologically active intestinal lymph. J Trauma 56 (2004) 105-110
37. van Santvoort H.C., Besselink M.G., Timmerman H.M., van Minnen L.P., Akkermans L.M., and Gooszen H.G. Probiotics in surgery. Surgery 143 (2008) 1-7
38. Wang X.D., Wang Q., Andersson R., and Ihse I. Alterations in intestinal function in acute pancreatitis in an experimental model. Br J Surg 83 (1996) 1537-1543
39. Foitzik T., Stufler M., Hotz H.G., Wagner J., Fromm M., and Buhr H.J. Glutamine stabilizes the intestinal barrier and reduces pancreatic infection in acute experimental pancreatitis. Langenbecks Archiv fur Chirurgie (1996) 463-466